Darou Pakhsh Holding (VPAKHSH)
- Ticker
- VPAKHSH
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Line of business
- Establishing and launching new companies, - participation in investment, - buying and holding company shares, - restructuring, renovating and launching various domestic and international companies - sale of shares - supporting affiliated companies in entering the Securities and Exchange Organization - transfer and exchange of shares
Latest trading day
Date: October 25, 2026
- Closing price
- 63,120 rials
- Change on the previous close
- +2.89%
- Volume
- 15,101,707 shares
- Trade value
- 95.31 billion tomans
- Market cap
- 53,021 billion tomans
VPAKHSH returns against the market, the dollar and gold
Up to the stock's last trade on October 25, 2026. Each row runs from the last price before the period starts to the latest price, and the stock's return is adjusted for capital raises and cash dividends. The indexes come from the Tehran Stock Exchange (TSETMC); the free-market dollar and 18k gold are daily free-market prices in tomans.
| Series | 1 month |
|---|---|
| VPAKHSH | 26.1% |
| Bourse total index | 12.6% |
| Farabourse total index | 17.1% |
| Free-market dollar | 15.2% |
| 18k gold (per gram) | 7.4% |
Weekly, 3-month, 1-year and 5-year returns, and the comparison with the industry, the Emami gold coin, the world gold ounce and Tehran housing, are on Fundai with free sign-up.
Key figures
| Item | Value | Basis |
|---|---|---|
| Listed NAV per share | 119,541 rials | Last trade to October 25, 2026 |
| Net listed asset value | 100,414 billion tomans | Last trade to October 25, 2026 |
| Holding's shares | 8,400,000,000 | monthly report to 1405/06/31 |
| Unlisted stakes, at cost | 81 billion tomans in 6 companies | monthly report to 1405/06/31 |
| Item | Market value today | Share of portfolio | Ownership |
|---|---|---|---|
| Darou Pakhsh Pharmaceutical Factories (DARU) | 46,297 billion tomans | 46.1% | 82.2% |
| Darou Pakhsh Pharmaceutical Distribution Company (DTOZI) | 18,856 billion tomans | 18.8% | 79.3% |
| Exir Pharmaceutical Company (DELER) | 14,900 billion tomans | 14.8% | 52.8% |
| Aburaihan Pharmaceutical Company (DABUR) | 11,185 billion tomans | 11.1% | 81.0% |
| Razak Pharmaceutical Company (DRAZAK) | 5,769 billion tomans | 5.7% | 51.3% |
| Zagros Pharmed Pars Pharmaceutical Company (DEDAM) | 1,198 billion tomans | 1.2% | 34.9% |
| Zahravi Pharmaceutical Company (DZAHRAVI) | 906 billion tomans | 0.9% | 14.2% |
| Pars Darou Company (DPARS) | 628 billion tomans | 0.6% | 3.6% |
| Caspian Tamin Pharmaceutical Company (KASPIAN) | 241 billion tomans | 0.2% | 0.7% |
| Farabi Pharmaceutical Company (DFARA) | 217 billion tomans | 0.2% | 1.1% |
| Item | Market value today | Share of portfolio |
|---|---|---|
| Pharmaceuticals | 100,414 billion tomans | 100.0% |
| Chemicals | 0 billion tomans | 0.0% |